These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 12094240)

  • 1. Chemoprevention: an essential approach to controlling cancer.
    Sporn MB; Suh N
    Nat Rev Cancer; 2002 Jul; 2(7):537-43. PubMed ID: 12094240
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The status of chemoprevention in the current cancer therapeutic armamentarium.
    Karamouzis MV
    J BUON; 2004; 9(4):363-72. PubMed ID: 17415841
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical Cancer Advances 2005: major research advances in cancer treatment, prevention, and screening--a report from the American Society of Clinical Oncology.
    Herbst RS; Bajorin DF; Bleiberg H; Blum D; Hao D; Johnson BE; Ozols RF; Demetri GD; Ganz PA; Kris MG; Levin B; Markman M; Raghavan D; Reaman GH; Sawaya R; Schuchter LM; Sweetenham JW; Vahdat LT; Vokes EE; Winn RJ; Mayer RJ;
    J Clin Oncol; 2006 Jan; 24(1):190-205. PubMed ID: 16326753
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical cancer advances 2006: major research advances in cancer treatment, prevention, and screening--a report from the American Society of Clinical Oncology.
    Ozols RF; Herbst RS; Colson YL; Gralow J; Bonner J; Curran WJ; Eisenberg BL; Ganz PA; Kramer BS; Kris MG; Markman M; Mayer RJ; Raghavan D; Reaman GH; Sawaya R; Schilsky RL; Schuchter LM; Sweetenham JW; Vahdat LT; Winn RJ;
    J Clin Oncol; 2007 Jan; 25(1):146-62. PubMed ID: 17158528
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypoxia-inducible factor 1 as a possible target for cancer chemoprevention.
    López-Lázaro M
    Cancer Epidemiol Biomarkers Prev; 2006 Dec; 15(12):2332-5. PubMed ID: 17164353
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stage matters: choosing relevant model systems to address hypotheses in diet and cancer chemoprevention research.
    Fenton JI; Hord NG
    Carcinogenesis; 2006 May; 27(5):893-902. PubMed ID: 16474168
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyclooxygenase-2 and epidermal growth factor receptor: pharmacologic targets for chemoprevention.
    Dannenberg AJ; Lippman SM; Mann JR; Subbaramaiah K; DuBois RN
    J Clin Oncol; 2005 Jan; 23(2):254-66. PubMed ID: 15637389
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An evidence-based approach to cancer prevention clinical trials.
    Greenwald P; McDonald SS; Anderson DE
    Eur J Cancer Prev; 2002 Aug; 11 Suppl 2():S43-7. PubMed ID: 12570334
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Annual report to the nation on the status of cancer, 1975-2002, featuring population-based trends in cancer treatment.
    Edwards BK; Brown ML; Wingo PA; Howe HL; Ward E; Ries LA; Schrag D; Jamison PM; Jemal A; Wu XC; Friedman C; Harlan L; Warren J; Anderson RN; Pickle LW
    J Natl Cancer Inst; 2005 Oct; 97(19):1407-27. PubMed ID: 16204691
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estimating the impact of new clinical trial proven cancer therapy and cancer chemoprevention on population mortality: the Karnofsky Memorial lecture.
    Unger JM; LeBlanc M; Crowley JJ; Grossman HB; Natale RB; Wozniak AJ; Berenson JR; List AF; Peters WA; Flanigan RC; Macdonald JS; Al-Sarraf M; Thompson IM; Coltman CA
    J Clin Oncol; 2003 Dec; 21(23 Suppl):246s-252s. PubMed ID: 14645404
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Cancer chemoprevention-basic and clinical aspects].
    Takayama T; Okamura S; Okahisa T; Kaji M; Takeuchi H; Kimura T
    Gan To Kagaku Ryoho; 2008 Jul; 35(7):1067-71. PubMed ID: 18633242
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tailoring cancer chemoprevention regimens to the individual.
    Conney AH
    J Cell Biochem; 2004 Feb; 91(2):277-86. PubMed ID: 14743388
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cancer chemoprevention: scientific promise, clinical uncertainty.
    Sporn MB; Liby KT
    Nat Clin Pract Oncol; 2005 Oct; 2(10):518-25. PubMed ID: 16205771
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanisms of disease: Inflammatory mediators and cancer prevention.
    Mann JR; Backlund MG; DuBois RN
    Nat Clin Pract Oncol; 2005 Apr; 2(4):202-10. PubMed ID: 16264935
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Review paper: Cancer chemopreventive compounds and canine cancer.
    Baek SJ; McEntee MF; Legendre AM
    Vet Pathol; 2009 Jul; 46(4):576-88. PubMed ID: 19276067
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of tea polyphenols on signal transduction pathways related to cancer chemoprevention.
    Hou Z; Lambert JD; Chin KV; Yang CS
    Mutat Res; 2004 Nov; 555(1-2):3-19. PubMed ID: 15476848
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The convergent development of molecular-targeted drugs for cancer treatment and prevention.
    Lippman SM; Heymach JV
    Clin Cancer Res; 2007 Jul; 13(14):4035-41. PubMed ID: 17634526
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fungal metabolites modulating NF-kappaB activity: an approach to cancer therapy and chemoprevention (review).
    Petrova RD; Reznick AZ; Wasser SP; Denchev CM; Nevo E; Mahajna J
    Oncol Rep; 2008 Feb; 19(2):299-308. PubMed ID: 18202775
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current and future status of prostate cancer chemoprevention.
    Fujimoto N; Nomura M; Matsumoto T
    Expert Rev Anticancer Ther; 2006 Jan; 6(1):59-71. PubMed ID: 16375645
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dichotomies in cancer research: some suggestions for a new synthesis.
    Sporn MB
    Nat Clin Pract Oncol; 2006 Jul; 3(7):364-73. PubMed ID: 16826217
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.